This week hosts Mark Masselli and Margaret Flinter speak with renowned virus expert Dr. William Haseltine who has ‘grave concerns’ about Merck’s oral COVID drug Malnupiravir, which recently won narrow approval from the FDA advisory panel. He says the drug unleashes ‘dangerous’ mutations that could evolve the virus beyond control. He’s also urging extreme caution as the highly infectious omicron variant is sweeping across the US, saying it could be as deadly as the delta variant and that boosters may offer only limited protection of 3 months. Dr Haseltine, who developed the Anthrax vaccine and is President of ACCESS Health International, says public health protocols of masking, rapid testing and social distancing should be put back in place during this next surge.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | Android | Podchaser | TuneIn | RSS | More
Originally broadcast October 2, 2025 The federal government is shut down and the ripple effects…
Originally broadcast Tuesday, September 23, 2025 Happy anniversary to “Conversations on Health Care”! We posted…
Dr. Wayne Jonas, who formerly led the National Institutes of Health Office of Alternative Medicine,…
Next week former Centers for Disease Control and Prevention Director Susan Monarez will testify in…
Supporters say Health and Human Services Secretary Robert F. Kennedy, Jr. is fulfilling his vision…
Originally broadcast Wednesday, August 27 Dr. Victor Montori, a Mayo Clinic endocrinologist, internationally recognized researcher,…